Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
10 mục trên mỗi trang (Trang 1 / 1) Tổng số 4 mục
06-08
06-06
05-30
05-29
05-26
05-25
05-10
04-25
04-25
04-24